To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spirometer Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.21 billion in 2023 to USD 2.64 billion by 2031, growing at a CAGR of 10.20% during the forecast period (2024-2031).

The spirometer market is made up of respiratory device manufacturers as well as standalone spirometer producers. New technical advancements, such as the use of artificial intelligence, will generate growth prospects for new market entrants. For example, NuvoAir, a Swedish health care firm, created a digital platform that allows customers to perform at-home lung function tests. Companies are battling for market share, particularly in nations with advanced technology such as the United Kingdom, Germany, and the United States. Acquisitions and cooperation amongst market participants to strengthen their position have occurred. This is projected to increase market competition over the projection period. 'Hill-Rom Holdings, Inc.', 'Schiller AG', 'MGC Diagnostics Corporation', 'Vitalograph Ltd.', 'Vyaire Medical, Inc.', 'ndd Medizintechnik AG', 'Midmark Corporation', 'Medical International Research (MIR)', 'COSMED srl', 'Fukuda Sangyo Co., Ltd.', 'Thor Medical Systems', 'Nihon Kohden Corporation', 'Ganshorn Medizin Electronic GmbH', 'SDI Diagnostics', 'Jones Medical Instrument Company', 'NDD EasyOne Diagnostics', 'Morgan Scientific Inc.', 'M&B Electronic Instruments Inc.', 'Futuremed America Inc.', 'CareFusion Corporation'

Despite the benefits of spirometry testing, there is a lack of awareness among patients and healthcare providers about its importance in the diagnosis and management of respiratory diseases. Additionally, the availability of spirometer devices may be limited in some regions, particularly in developing countries, which may limit the market's growth potential.

Increasing adoption of portable and handheld spirometer devices: There is a growing trend toward the adoption of portable and handheld spirometer devices that are easy to use and provide accurate and reliable results. These devices are particularly useful in primary care settings and home healthcare settings, where they can be used to monitor patients with respiratory conditions and track changes in lung function over time.

North America dominated the market with a 41.6% share in 2022, owing mostly to the rising frequency of respiratory disorders. As the number of COPD and asthma cases rises, so does the usage of spirometers, which help in disease control and are routinely used by doctors in hospitals. Furthermore, the US has been highlighted as an early adopter of technology that aids in the decrease of COPD rates. Due to the one preceding, the market is expected to expand throughout the forecast period.

Feedback From Our Clients

Global Spirometer Market

Product ID: SQMIG35A2503

$5,300
BUY NOW